Trinity Biotech (TRIB) Revenue Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5.75% |
| Sep 30, 2024 | -9.23% |
| Jun 30, 2024 | -6.77% |
| Mar 31, 2024 | -7.76% |
| Dec 31, 2023 | -11.35% |
| Sep 30, 2023 | -9.15% |
| Jun 30, 2023 | -11.08% |
| Mar 31, 2023 | -9.03% |
| Dec 31, 2022 | -8.53% |
| Sep 30, 2022 | -9.31% |
| Jun 30, 2022 | -9.54% |
| Mar 31, 2022 | -7.81% |
| Dec 31, 2021 | -3.79% |
| Sep 30, 2021 | -3.38% |
| Jun 30, 2021 | -0.34% |
| Mar 31, 2021 | 1.71% |
| Dec 31, 2020 | 5.61% |
| Sep 30, 2020 | 4.44% |
| Jun 30, 2020 | -7.96% |
| Mar 31, 2020 | -3.45% |
| Dec 31, 2019 | -4.39% |
| Sep 30, 2019 | -1.97% |
| Jun 30, 2019 | -2.86% |
| Mar 31, 2019 | -2.52% |
| Dec 31, 2018 | -0.74% |
| Sep 30, 2018 | -0.34% |
| Jun 30, 2018 | 3.25% |
| Mar 31, 2018 | 3.20% |
| Dec 31, 2017 | 3.35% |
| Sep 30, 2017 | 4.19% |
| Jun 30, 2017 | 4.11% |
| Mar 31, 2017 | 3.28% |
| Dec 31, 2016 | 3.42% |
| Sep 30, 2016 | 5.67% |
| Jun 30, 2016 | 6.21% |
| Mar 31, 2016 | 4.74% |
| Dec 31, 2015 | 5.32% |
| Sep 30, 2015 | 6.56% |
| Jun 30, 2015 | 1.40% |
| Mar 31, 2015 | -2.75% |
| Dec 31, 2014 | -2.83% |
| Sep 30, 2014 | -3.05% |
| Jun 30, 2014 | -4.24% |
| Mar 31, 2014 | -4.26% |